Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Huayuan Zhu, Hui Shen, Yilian Yang, Chong-Yang Ding, MD, Yeqin Sha, Hongling Mi, Jingyan Qiu, Ruize Chen, Yujie Wu, Chun Qiao, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-141747

Published: 2020

Journal Articles

Tumor Microenvironment Associated with Complete Response to Tislelizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma Reveals a Potentially Different Mechanism of Action

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-136696

Published: 2020

Journal Articles

Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma

Blood (2019) 134 (Supplement_1): 50.

https://doi.org/10.1182/blood-2019-125372

Published: 2019

Journal Articles

Laterality and Survival Outcomes in Patients with Primary Testicular Diffuse Large B Cell Lymphoma

Yi Miao, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 2903.

https://doi.org/10.1182/blood-2019-129952

Published: 2019

Journal Articles

Genomic Landscape of Chinese Patients with Chronic Lymphocytic Leukemia By Whole-Exome Sequencing

Yi Miao, MD PhD, Yi Xia, Chun Qiao, Huayuan Zhu, Jiazhu Wu, MD, Hui Jin, Jianxin Fu, MD PhD, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 2784.

https://doi.org/10.1182/blood-2019-127813

Published: 2019

Journal Articles

SHC014748M, a Novel Selective Inhibitor of PI3Kδ, Demonstrates Promising Pre-Clinical Antitumor Activity in B Cell Lymphomas and CLL

Lei Fan, MD PhD, Chao Wang, Zhiqiang Wang, Xian Zhang, Lei Cao, Yi Miao, MD PhD, Xinyi Du, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 5306.

https://doi.org/10.1182/blood-2019-129469

Published: 2019

Journal Articles

Association of Insurance Status and Marital Status with Outcomes of Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Yi Miao, MD PhD, Wei Xu, MD PhD, Lei Fan, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 5459.

https://doi.org/10.1182/blood-2019-127756

Published: 2019

Journal Articles

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Yi Xia, Jianxin Fu, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Li Wang, MD

Blood (2019) 134 (Supplement_1): 4284.

https://doi.org/10.1182/blood-2019-124609

Published: 2019

Journal Articles

98% IGHV Gene Identity Is Still the Optimal Cutoff to Predict the Prognosis of Chronic Lymphocytic Leukemia Patients in China

Yi Xia, Ke Shi, Qian Sun, Chun Qiao, Huayuan Zhu, Li Wang, MD, Lei Fan, MD PhD, Wei Xu, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5545.

https://doi.org/10.1182/blood-2018-99-118141

Published: 2018

Journal Articles

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Yuqin Song, MD PhD, Quanli Gao, MD, Huilai Zhang, PhD, Lei Fan, MD PhD, Jianfeng Zhou, PhD, Dehui Zou, MD, Wei Li, MD, Haiyan Yang, PhD, Ting Liu, MD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Yu Yang, MD, Haiyi Guo, MD, Liudi Yang, MD, Rebecca Elstrom, MD, Jane Huang, MD, William Novotny, MD, Vivian Wei, PhD, Jun Zhu, MD PhD

Blood (2018) 132 (Supplement 1): 682.

https://doi.org/10.1182/blood-2018-99-117848

Published: 2018

Journal Articles

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jian-Yong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2848.

https://doi.org/10.1182/blood.V130.Suppl_1.2848.2848

Published: 2017

Journal Articles

Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma

Rui Gao, MD, Wei Xu, MDPhD, Jin-Hua Liang, MD, Li Wang, MD, Lei Fan, MD PhD, Tao Yang, MD PhD, Jianyong Li, MD PhD

Blood (2017) 130 (Supplement 1): 2849.

https://doi.org/10.1182/blood.V130.Suppl_1.2849.2849

Published: 2017

Journal Articles

Serum Immunoglobulin Paraprotein Associated with Inferior Progression Free Survival in Patients with Mucosa-Associated Lymphoid Tissue Lymphoma

Min Xu, Qian Zhao, Yue Li, Lei Fan, MD PhD, Yi Xia, Li Wang, MD, Jianyong Li, MD PhD, Wei Xu, MDPhD

Blood (2017) 130 (Supplement 1): 5157.

https://doi.org/10.1182/blood.V130.Suppl_1.5157.5157

Published: 2017

Journal Articles

Genomic Landscape of Chronic Lymphocytic Leukemia in China By Targeted Gene Sequencing

Yi Miao, MD PhD, Yi Xia, Lei Fan, MD PhD, Wei Xu, MDPhD, Jianyong Li, MD PhD

Blood (2017) 130 (Supplement 1): 4298.

https://doi.org/10.1182/blood.V130.Suppl_1.4298.4298

Published: 2017

Journal Articles

Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18 f-FDG PET/CT in Patients with Follicular Lymphoma

Jin-Hua Liang, MD, Wei Xu, MDPhD, Chong-Yang Ding, MD, Li Wang, MD, Lei Fan, MD PhD, Jian-Yong Li, MD PhD

Blood (2017) 130 (Supplement 1): 4047.

https://doi.org/10.1182/blood.V130.Suppl_1.4047.4047

Published: 2017

Journal Articles

Targeted Gene Sequencing of Adult Patients with Hemophagocytic Lymphohistiocytosis

Yi Miao, MD PhD, Yuqing Miao, Yi Xia, Yi-Ling Kong, Lei Fan, MD PhD, Wei Xu, Jianyong Li, MD PhD

Blood (2017) 130 (Supplement 1): 3572.

https://doi.org/10.1182/blood.V130.Suppl_1.3572.3572

Published: 2017

Journal Articles

TP53-Induced Glycolysis and Apoptosis Regulator Protects from Spontaneous Apoptosis and Predicts Poor Prognosis in Chronic Lymphocytic Leukemia

Ming Hong, Yi Xia, Yu Zhu, MD, Huihui Zhao, Yue Xie, Lei Fan, MD, PhD, Li Wang, Kourong Miao, MD, Wei Wu, Huayuan Zhu, MD, Yaoyu Chen, Wei Xu, Sixuan Qian, Jianyong Li

Blood (2016) 128 (22): 5101.

https://doi.org/10.1182/blood.V128.22.5101.5101

Published: 2016

Journal Articles

Differential Diagnosis of Lymphoid Enhancer-Binding Factor 1 Between Chronic Lymphocytic Leukemia and Other B-Cell Chronic Lymphoproliferative Disorders

Lei Fan, MD, PhD, Tingmei Shen, Rong Wang, Yi Miao, Yujie Wu, Hui Yang, Li Wang, Wei Xu, Jianyong Li, MD PhD

Blood (2015) 126 (23): 4148.

https://doi.org/10.1182/blood.V126.23.4148.4148

Published: 2015

Journal Articles

Prognostic Significance of Bone Marrow Infiltration Detected By PET-CT in Newly Diagnosed Diffuse Large B Cell Lymphoma

Jin-Hua Liang, Jin Sun, Li Wang, Lei Fan, MD, PhD, Li Tian-Nv, Jian-Yong Li, MD PhD, Wei Xu

Blood (2015) 126 (23): 1473.

https://doi.org/10.1182/blood.V126.23.1473.1473

Published: 2015

Journal Articles

Chinese External Validation of the Cochrane Haematological Malignancies Group Prognostic Index for Chronic Lymphocytic Leukemia Patients

Shu Chao Qin, Wei Xu, Yi Xia, Chun Qiao, Lei Fan, MD, PhD, Li Wang, Yao Yu Chen, Jianyong Li, MD PhD

Blood (2015) 126 (23): 5280.

https://doi.org/10.1182/blood.V126.23.5280.5280

Published: 2015

NARROW

Ibrutinib Plus Fludarabine, Cyclophosphamide, and Rituximab As the Treatment for Chronic Lymphocytic Leukemia/ Small Lymphocytic Leukemia: A Single-Center Real World Study

Tumor Microenvironment Associated with Complete Response to Tislelizumab Monotherapy in Relapsed/Refractory Classical Hodgkin Lymphoma Reveals a Potentially Different Mechanism of Action

Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma

Laterality and Survival Outcomes in Patients with Primary Testicular Diffuse Large B Cell Lymphoma

Genomic Landscape of Chinese Patients with Chronic Lymphocytic Leukemia By Whole-Exome Sequencing

SHC014748M, a Novel Selective Inhibitor of PI3Kδ, Demonstrates Promising Pre-Clinical Antitumor Activity in B Cell Lymphomas and CLL

Association of Insurance Status and Marital Status with Outcomes of Patients with Chronic Lymphocytic Leukemia: A Population-Based Study

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

98% IGHV Gene Identity Is Still the Optimal Cutoff to Predict the Prognosis of Chronic Lymphocytic Leukemia Patients in China

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Type 2 Diabetes Mellitus Strongly Impacts Survival in Patients with Diffuse Large B Cell Lymphoma

Low Serum Cholesterol Levels Predict Inferior Prognosis in Diffuse Large B Cell Lymphoma

Serum Immunoglobulin Paraprotein Associated with Inferior Progression Free Survival in Patients with Mucosa-Associated Lymphoid Tissue Lymphoma

Genomic Landscape of Chronic Lymphocytic Leukemia in China By Targeted Gene Sequencing

Prognostic Value of Baseline and Interim Total Metabolic Tumour Volume and Total Lesion Glycolysis Measured on 18 f-FDG PET/CT in Patients with Follicular Lymphoma

Targeted Gene Sequencing of Adult Patients with Hemophagocytic Lymphohistiocytosis

TP53-Induced Glycolysis and Apoptosis Regulator Protects from Spontaneous Apoptosis and Predicts Poor Prognosis in Chronic Lymphocytic Leukemia

Differential Diagnosis of Lymphoid Enhancer-Binding Factor 1 Between Chronic Lymphocytic Leukemia and Other B-Cell Chronic Lymphoproliferative Disorders

Prognostic Significance of Bone Marrow Infiltration Detected By PET-CT in Newly Diagnosed Diffuse Large B Cell Lymphoma

Chinese External Validation of the Cochrane Haematological Malignancies Group Prognostic Index for Chronic Lymphocytic Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only